H.R. 2343 · Where this bill is now
In committee
Introduced in the House, sent to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned, Mar 25, 2025
What this bill does
In plain words · AI-written from the official summaryMedicare covers at-home treatment for alpha-1 deficiency
This bill adds a specific treatment to what Medicare will pay for: augmentation therapy given at home for people with emphysema caused by a rare genetic condition called alpha-1 antitrypsin deficiency. The treatment has to be delivered by qualified home infusion therapy suppliers, and patients need to be under the care of a doctor, nurse practitioner, or physician assistant.
How it affects you
If you're a Medicare beneficiary with severe hereditary alpha-1 antitrypsin deficiency and emphysema, this change means you could receive treatment at home instead of traveling to a clinic or hospital, and Medicare would cover it. For others, this is a specialized benefit that doesn't directly affect them.
Read the official summary (Introduced in House, Mar 25, 2025)
John W. Walsh Alpha-1 Home Infusion Act of 2025
This bill provides for Medicare coverage of treatment for alpha-1 antitrypsin (AAT) deficiency (a protein deficiency that raises the risk of lung and other diseases). Specifically, the bill provides for coverage of at-home augmentation therapy for beneficiaries with emphysema as a result of severe hereditary AAT deficiency. Treatment must be provided through qualified home infusion therapy suppliers; beneficiaries must be under the care of a physician, nurse practitioner, or physician assistant.
Written by AI (Claude) using only the official summary by the Congressional Research Service, the Library of Congress’s nonpartisan research staff. It can miss nuance, so check the official summary and the bill text for details.
1st SessionH. R. 2343
A BILL
John W. Walsh Alpha-1 Home Infusion Act of 2025
Sponsor: Rep. Maria Elvira Salazar (R-FL-27) · Introduced Mar 25, 2025 · Health · 1 version of the text
Sources: Congress.gov actions and votes · bill text from GovInfo · latest official action Mar 25, 2025: “Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.”